NIH-directed purge of researchers with China ties sweeps up Moffitt CEO Alan List, colleagues

Amber Tong

In an escalation of the already heightened sentiments around threats of academic espionage, Moffitt Cancer Center said Alan List, its president and CEO, and center director Thomas Sellers have resigned for violating conflict of interest rules through their work in China.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

NIH-directed purge of researchers with China ties sweeps up Moffitt CEO Alan List, colleagues

Amber Tong

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

NIH-di­rect­ed purge of re­searchers with Chi­na ties sweeps up Mof­fitt CEO Alan List, col­leagues

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

NIH-directed purge of researchers with China ties sweeps up Moffitt CEO Alan List, colleagues